Emergence of depressive symptoms in patients receiving alprazolam for panic disorder
- 1 May 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (5) , 664-665
- https://doi.org/10.1176/ajp.144.5.664
Abstract
The authors relate their clinical experience with 46 panic disorder patients who were receiving 3-10 mg/day of alprazolam. Fifteen (33%) developed symptoms consistent with DSM-III criteria for major depression despite remission of their panic symptoms. Clinicians should be alert to this potentially reversible complication.This publication has 6 references indexed in Scilit:
- Alprazolam vs Amitriptyline in Depressions With Reduced REM LatenciesArchives of General Psychiatry, 1985
- Alprazolam, Amitriptyline, Doxepin, and Placebo in the Treatment of DepressionArchives of General Psychiatry, 1985
- Longitudinal course of panic disorder: Clinical and biological considerationsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1985
- Comparison of alprazolam, imipramine, and placebo in the treatment of depressionJAMA, 1983
- Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled studyPsychopharmacology, 1982
- Increase in Suicidal Thoughts and TendenciesPublished by American Medical Association (AMA) ,1968